Cargando…

Experimental Induction of Paromomycin Resistance in Antimony-Resistant Strains of L. donovani: Outcome Dependent on In Vitro Selection Protocol

Paromomycin (PMM) has recently been introduced for treatment of visceral leishmaniasis in India. Although no clinical resistance has yet been reported, proactive vigilance should be warranted. The present in vitro study compared the outcome and stability of experimental PMM-resistance induction on p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hendrickx, Sarah, Inocêncio da Luz, Raquel Andrea, Bhandari, Vasundhra, Kuypers, Kristel, Shaw, Craig D., Lonchamp, Julien, Salotra, Poonam, Carter, Katharine, Sundar, Shyam, Rijal, Suman, Dujardin, Jean-Claude, Cos, Paul, Maes, Louis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362622/ https://www.ncbi.nlm.nih.gov/pubmed/22666513 http://dx.doi.org/10.1371/journal.pntd.0001664

Ejemplares similares

Transcriptome profiling identifies genes/pathways associated with experimental resistance to paromomycin in Leishmania donovani
por: Verma, Aditya, et al.
Publicado: (2017)

Comparative Fitness of a Parent Leishmania donovani Clinical Isolate and Its Experimentally Derived Paromomycin-Resistant Strain
por: Hendrickx, Sarah, et al.
Publicado: (2015)

Antimonial Resistance in Leishmania donovani Is Associated with Increased In Vivo Parasite Burden
por: Vanaerschot, Manu, et al.
Publicado: (2011)

Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress
por: Deep, Deepak Kumar, et al.
Publicado: (2017)

Genomic and Metabolomic Polymorphism among Experimentally Selected Paromomycin-Resistant Leishmania donovani Strains
por: Shaw, C. D., et al.
Publicado: (2019)

Treatment of Visceral Leishmaniasis: Model-Based Analyses on the Spread of Antimony-Resistant L. donovani in Bihar, India
por: Stauch, Anette, et al.
Publicado: (2012)

Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent
por: Dumetz, F., et al.
Publicado: (2018)

Experimental Selection of Paromomycin Resistance in Leishmania donovani Amastigotes Induces Variable Genomic Polymorphisms
por: Hendrickx, Sarah, et al.
Publicado: (2021)

Paromomycin Affects Translation and Vesicle-Mediated Trafficking as Revealed by Proteomics of Paromomycin –Susceptible –Resistant Leishmania donovani
por: Chawla, Bhavna, et al.
Publicado: (2011)

Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum
por: Hendrickx, Sarah, et al.
Publicado: (2017)

Imipramine Is an Orally Active Drug against Both Antimony Sensitive and Resistant Leishmania donovani Clinical Isolates in Experimental Infection
por: Mukherjee, Sandip, et al.
Publicado: (2012)

Role of Efflux Pumps and Intracellular Thiols in Natural Antimony Resistant Isolates of Leishmania donovani
por: Rai, Smita, et al.
Publicado: (2013)

Antimony Resistant Leishmania donovani but Not Sensitive Ones Drives Greater Frequency of Potent T-Regulatory Cells upon Interaction with Human PBMCs: Role of IL-10 and TGF-β in Early Immune Response
por: Guha, Rajan, et al.
Publicado: (2014)

In vitro selection of miltefosine resistance in promastigotes of Leishmania donovani from Nepal: genomic and metabolomic characterization
por: Shaw, C. D., et al.
Publicado: (2016)

Drug Susceptibility in Leishmania Isolates Following Miltefosine Treatment in Cases of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis
por: Bhandari, Vasundhra, et al.
Publicado: (2012)

Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex
por: Downing, Tim, et al.
Publicado: (2012)

Linking In Vitro and In Vivo Survival of Clinical Leishmania donovani Strains
por: Vanaerschot, Manu, et al.
Publicado: (2010)

Genomic and Transcriptomic Analysis for Identification of Genes and Interlinked Pathways Mediating Artemisinin Resistance in Leishmania donovani
por: Ghosh, Sushmita, et al.
Publicado: (2020)

Short-Course Treatment With Imipramine Entrapped in Squalene Liposomes Results in Sterile Cure of Experimental Visceral Leishmaniasis Induced by Antimony Resistant Leishmania donovani With Increased Efficacy
por: Mukherjee, Sandip, et al.
Publicado: (2020)

Leishmania donovani Isolates with Antimony-Resistant but Not -Sensitive Phenotype Inhibit Sodium Antimony Gluconate-Induced Dendritic Cell Activation
por: Haldar, Arun Kumar, et al.
Publicado: (2010)

Evaluation of a Possible Synergistic Effect of Meglumine Antimoniate with Paromomycin, Miltefosine or Allopurinol on in Vitro Susceptibility of Leishmania tropica Resistant Isolate
por: REZAEI RIABI, Tahereh, et al.
Publicado: (2013)

Antimony Toxicity
por: Sundar, Shyam, et al.
Publicado: (2010)

Zinc depletion promotes apoptosis-like death in drug-sensitive and antimony-resistance Leishmania donovani
por: Saini, Shalini, et al.
Publicado: (2017)

Risk Factors for Visceral Leishmaniasis and Asymptomatic Leishmania donovani Infection in India and Nepal
por: Picado, Albert, et al.
Publicado: (2014)

Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis
por: Sundar, Shyam, et al.
Publicado: (2014)

Proteomic Analysis of Leishmania donovani Membrane Components Reveals the Role of Activated Protein C Kinase in Host-Parasite Interaction
por: Verma, Sandeep, et al.
Publicado: (2021)

Mitochondrial Associated Ubiquitin Fold Modifier-1 Mediated Protein Conjugation in Leishmania donovani
por: Gannavaram, Sreenivas, et al.
Publicado: (2011)

A novel marker, ARM58, confers antimony resistance to Leishmania spp.()
por: Nühs, Andrea, et al.
Publicado: (2013)

Incidence of Symptomatic and Asymptomatic Leishmania donovani Infections in High-Endemic Foci in India and Nepal: A Prospective Study
por: Ostyn, Bart, et al.
Publicado: (2011)

Phase 4 Pharmacovigilance Trial of Paromomycin Injection for the Treatment of Visceral Leishmaniasis in India
por: Sinha, Prabhat K., et al.
Publicado: (2011)

Integrative genomic, proteomic and phenotypic studies of Leishmania donovani strains revealed genetic features associated with virulence and antimony-resistance
por: Zheng, Zhiwan, et al.
Publicado: (2020)

A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical Leishmania donovani Isolates of the Indian Subcontinent Exhibiting Resistance to Multiple Drugs
por: Ghosh, Souradeepa, et al.
Publicado: (2021)

Integrated genomic and metabolomic profiling of ISC1, an emerging Leishmania donovani population in the Indian subcontinent
por: Cuypers, Bart, et al.
Publicado: (2018)

Role of CD8(+) T cells in protection against Leishmania donovani infection in healed Visceral Leishmaniasis individuals
por: Kaushal, Himanshu, et al.
Publicado: (2014)

Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial
por: Picado, Albert, et al.
Publicado: (2010)

Relapse after Treatment with Miltefosine for Visceral Leishmaniasis Is Associated with Increased Infectivity of the Infecting Leishmania donovani Strain
por: Rai, Keshav, et al.
Publicado: (2013)

In Vitro Assessment of Antifungal Caspofungin on Leishmania donovani Culture Isolation
por: Bhattarai, Narayan Raj, et al.
Publicado: (2017)

Single locus genotyping to track Leishmania donovani in the Indian subcontinent: Application in Nepal
por: Rai, Keshav, et al.
Publicado: (2017)

Over-Expression of Cysteine Leucine Rich Protein Is Related to SAG Resistance in Clinical Isolates of Leishmania donovani
por: Das, Sanchita, et al.
Publicado: (2015)

Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis
por: Parvez, Shabi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5hsimuof35vcj93sqd33mbipah